We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $999B
1-Year Est. Return 46.22%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+1.52%
1 Year Est. Return
+46.22%
3 Year Est. Return
+150.45%
5 Year Est. Return
+185.95%
10 Year Est. Return
+1,389.53%
AUM
$486B
AUM Growth
+$2.12B
Cap. Flow
+$867M
Cap. Flow %
0.18%
Top 10 Hldgs %
13.96%
Holding
2,615
New
76
Increased
1,051
Reduced
777
Closed
79

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.76B
2
CI icon
Cigna
CI
+$1.44B
3
BMY icon
Bristol-Myers Squibb
BMY
+$1.26B
4
OXY icon
Occidental Petroleum
OXY
+$763M
5
DHR icon
Danaher
DHR
+$762M

Sector Composition

Rank Sector Weight
1 Healthcare 23.37%
2 Financials 13.66%
3 Consumer Discretionary 13.64%
4 Technology 10.86%
5 Industrials 10.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNTA
626
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$90.9M 0.02%
3,983,714
-433,972
-10% -$8.64M
PB icon
627
Prosperity Bancshares
PB
$9.01B
$90.7M 0.02%
1,571,060
+168,020
+12% +$9.14M
PRGS icon
628
Progress Software
PRGS
$1.8B
$90.7M 0.02%
3,296,657
-22,570
-0.7% -$602K
INTU icon
629
Intuit
INTU
$95.2B
$90.6M 0.02%
898,917
+107,216
+14% +$10.9M
WTFC icon
630
Wintrust Financial
WTFC
$11B
$90.1M 0.02%
1,687,460
-460,226
-21% -$23.2M
TMUSP
631
DELISTED
T-Mobile US, Inc.5.50% Mandatory Convertible Preferred Stock, Series A
TMUSP
$89.6M 0.02%
1,309,500
-697,500
-35% -$45.2M
COF icon
632
Capital One
COF
$139B
$89.1M 0.02%
1,012,933
+577
+0.1% +$48.5K
LFUS icon
633
Littelfuse
LFUS
$11.6B
$88.9M 0.02%
937,210
-18,640
-2% -$1.82M
FIVE icon
634
Five Below
FIVE
$13.5B
$88.8M 0.02%
2,245,300
-2,232,730
-50% -$81.1M
ENV
635
DELISTED
ENVESTNET, INC.
ENV
$88.6M 0.02%
2,190,500
+701,149
+47% +$33.7M
CHS
636
DELISTED
Chicos FAS, Inc.
CHS
$88.3M 0.02%
5,312,330
-71,600
-1% -$1.22M
BAX icon
637
Baxter International
BAX
$13.8B
$88.2M 0.02%
2,321,748
+433,657
+23% +$16.2M
POR icon
638
Portland General Electric
POR
$5.96B
$88M 0.02%
2,653,470
+2,155,950
+433% +$75.6M
PKG icon
639
Packaging Corp of America
PKG
$22.7B
$87.6M 0.02%
1,401,921
-211,598
-13% -$14.9M
CRAY
640
DELISTED
Cray, Inc.
CRAY
$87.4M 0.02%
2,960,747
+23,310
+0.8% +$706K
ACC
641
DELISTED
American Campus Communities, Inc.
ACC
$87.2M 0.02%
2,314,289
+383,123
+20% +$15.4M
CDP icon
642
COPT Defense Properties
CDP
$4.24B
$87.1M 0.02%
3,702,170
+2,657,580
+254% +$70.8M
HCSG icon
643
Healthcare Services Group
HCSG
$1.48B
$86.9M 0.02%
2,630,786
-1,474
-0.1% -$46.4K
CVT
644
DELISTED
CVENT, INC.
CVT
$86.9M 0.02%
3,371,419
+570,903
+20% +$15.5M
ROSE
645
DELISTED
ROSETTA RESOURCES INC
ROSE
$85.9M 0.02%
3,713,110
+250,315
+7% +$5.72M
PCL
646
DELISTED
PLUM CREEK TIMBER CO (REIT)
PCL
$85.8M 0.02%
2,116,020
+22,935
+1% +$962K
DATA
647
DELISTED
Tableau Software, Inc.
DATA
$85.2M 0.02%
738,536
-12,064
-2% -$1.3M
STRA icon
648
Strategic Education
STRA
$1.84B
$85.1M 0.02%
1,975,155
+74,329
+4% +$3.64M
TS icon
649
Tenaris
TS
$27B
$85M 0.02%
3,146,468
+44,240
+1% +$1.32M
BLMN icon
650
Bloomin' Brands
BLMN
$901M
$84.8M 0.02%
3,970,454
-31,290
-0.8% -$704K

Similar funds

T. Rowe Price Associates's Q2 2015 Portfolio in Review

As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
  • T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
  • T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
  • T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
  • T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
  • T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
  • T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.

Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.